ASRS
KRYS icon

Arizona State Retirement System’s Krystal Biotech KRYS Stock Holding History

Arizona State Retirement System’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.11M Sell
5,686
-287
-5% -$85.8K 0.01% 778
2026
Q1 		$1.54M Sell
5,973
-65
-1% -$17.3K 0.01% 861
2025
Q4 		$1.49M Sell
6,038
-359
-6% -$75.6K 0.01% 905
2025
Q3 		$1.13M Buy
6,397
+81
+1% +$12.1K 0.01% 1075
2025
Q2 		$868K Buy
6,316
+145
+2% +$21.3K 0.01% 1171
2025
Q1 		$1.11M Sell
6,171
-71
-1% -$11.9K 0.01% 1005
2024
Q4 		$978K Buy
6,242
+487
+8% +$86.4K 0.01% 1111
2024
Q3 		$1.05M Buy
5,755
+608
+12% +$117K 0.01% 1075
2024
Q2 		$945K Buy
5,147
+108
+2% +$18.1K 0.01% 1058
2024
Q1 		$897K Sell
5,039
-48
-0.9% -$6.67K 0.01% 1099
2023
Q4 		$631K Sell
5,087
-9
-0.2% -$998 ﹤0.01% 1316
2023
Q3 		$591K Sell
5,096
-336
-6% -$41K 0.01% 1282
2023
Q2 		$638K Buy
5,432
+210
+4% +$21.4K 0.01% 1283
2023
Q1 		$418K Buy
5,222
+153
+3% +$12K ﹤0.01% 1513
2022
Q4 		$402K Buy
5,069
+193
+4% +$14.3K ﹤0.01% 1499
2022
Q3 		$340K Buy
4,876
+158
+3% +$11.4K ﹤0.01% 1555
2022
Q2 		$310K Buy
4,718
+6
+0.1% +$373 ﹤0.01% 1654
2022
Q1 		$314K Buy
4,712
+827
+21% +$51.6K ﹤0.01% 1768
2021
Q4 		$272K Sell
3,885
-46
-1% -$2.68K ﹤0.01% 1890
2021
Q3 		$205K Buy
3,931
+58
+1% +$3.43K ﹤0.01% 2062
2021
Q2 		$263K Buy
3,873
+144
+4% +$10.1K ﹤0.01% 1954
2021
Q1 		$287K Buy
3,729
+23
+0.6% +$1.67K ﹤0.01% 1836
2020
Q4 		$222K Buy
+3,706
New +$185K ﹤0.01% 1899

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Arizona State Retirement System's KRYS Position: Q2 2026 in Review

Arizona State Retirement System reduced its Krystal Biotech (KRYS) stake by 4.8% in Q2 2026, selling an estimated $85.8K and leaving 5,686 shares worth $2.11M. The position accounts for 0.01% of the portfolio, ranked #778.

Arizona State Retirement System first reported a position in KRYS in Q4 2020 and has held it in 23 quarters since. 424 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Arizona State Retirement System held 5,686 shares of Krystal Biotech worth $2.11M as of Q2 2026.
  • Arizona State Retirement System sold 287 Krystal Biotech shares in Q2 2026, an estimated $85.8K.
  • Krystal Biotech made up 0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #778 holding.
  • Arizona State Retirement System first reported a position in Krystal Biotech in Q4 2020 and has held it in 23 quarters since.
  • 424 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.